SIERRA SUMMIT ADVISORS LLC
Position in RIGL — Rigel Pharmaceuticals Inc
CIK 2012614
INCLINE VILLAGE, NV
Position in RIGL
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,246,989
+$669,496 QoQ
Shares Held
31,876
+49.3% QoQ
Ownership
0.171%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#62
of 156 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RIGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SIERRA SUMMIT ADVISORS LLC holds $27,426,154 across 7 Biotechnology names. RIGL ranks #3 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
41,684 | $12,548,134 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,678 | $9,152,320 | |
| 3 | RIGL |
Rigel Pharmaceuticals Inc
This page
|
31,876 | $1,246,989 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
21,173 | $1,211,519 | |
| 5 | RPRX |
Royalty Pharma plc
|
20,842 | $1,168,610 | |
| 6 | XOMA |
XOMA Royalty Corp
|
25,740 | $1,093,950 | |
| 7 | TBPH |
Theravance Biopharma, Inc.
|
59,096 | $1,004,632 |
All Filings in RIGL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,246,989 | 31,876 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $577,493 | 21,357 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $959,434 | 22,401 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $855,169 | 30,186 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $698,048 | 37,269 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||